# The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

> **NCT00727948** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Vermont** · enrollment: 11 (actual)

## Conditions studied

- Breast Cancer
- Angiogenesis

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00727948
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-12
- **Final completion:** 2012-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727948, "The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00727948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*